Racist Factors Underlying Prostate Cancer Disparities
Menée à partir des données des registes américains des cancers et de la base Medicare portant sur 39 534 patients atteints d'un cancer localisé de la prostate diagnostiqué entre 2011 et 2015, cette étude de cohorte identifie les facteurs associés à l'existence de disparités ethniques dans l'utilisation de l'imagerie par résonance magnétique (IRM)
Much work has been done in documenting the disparities between US Black and White individuals across different domains of medicine. For prostate cancer, in particular, Black men are more likely to present at an advanced stage, less likely to undergo surgical resection, and have higher overall mortality.1 However, the bulk of the literature on racial disparities has focused on documenting the differences in outcomes between Black and White men without understanding the structural factors that shape them. Many authors identify biological differences as the potential underlying cause in these disparities, with multiple works going so far as to study genetic polymorphisms as the root cause of racial disparities.2 However, this remains an ill-conceived and naive method of measuring differences between socially imposed categories of racial groups. Race is representative of directed discriminatory practices, but medical literature rarely addresses these issues.
JAMA Oncology , commentaire, 2021